APPLICATION
ANDA078502
TYPE
ANDA
ORIGINAL APPROVAL
2008-11-24
LATEST ACTION
2012-07-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ELIPHOSDiscontinued
CALCIUM ACETATE 667MG · TABLET · ORAL
Approval history
2012-07-12Labeling · Supplement 6 · standardAP
2009-06-03Labeling · Supplement 5AP
2009-03-20Labeling · Supplement 3AP
2009-03-18Labeling · Supplement 4AP
2009-01-21Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.